Codexis (CDXS) Equity Average (2011 - 2026)
Codexis (CDXS) recorded quarterly Equity Average of $46.9 million in Q1 2026, up 5.27% quarter-over-quarter from $44.5 million in Q4 2025, and down 19.56% on a YoY basis from $58.3 million in Q1 2025.
Codexis (CDXS) Equity Average (2011 - 2026) Analysis & Trends
Codexis' Equity Average history runs 16 years deep, the most recent figure standing at $46.9 million for Q1 2026.
- In Q1 2026, Equity Average fell 19.56% year-over-year to $46.9 million; the TTM figure through Mar 2026 stood at $46.9 million (down 19.56% YoY), while the FY2025 annual figure was $58.7 million, down 23.5% from the prior year.
- Equity Average was $46.9 million for Q1 2026 at Codexis, up from $44.5 million in the prior quarter.
- In the past five years, Equity Average ranged from a high of $161.5 million in Q1 2022 to a low of $44.5 million in Q4 2025.
- Historically, Equity Average has averaged $95.6 million across 5 years, with a median of $82.9 million in 2024.
- The sharpest annual moves came in 2022 and 2024: Equity Average slipped 2.58% in 2022, then slumped 43.75% in 2024.
- A 5-year view of Equity Average shows it stood at $149.5 million in 2022, then sank by 40.41% to $89.1 million in 2023, then declined by 21.22% to $70.2 million in 2024, then sank by 36.52% to $44.5 million in 2025, then gained by 5.27% to $46.9 million in 2026.
- The last three Equity Average figures came in at $46.9 million (Q1 2026), $44.5 million (Q4 2025), and $47.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 3.50 Bn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 783.14 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 3.76 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 1.01 Bn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 21.35 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 19.01 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 516.41 Mn |
| 10 | Codexis | 236.00 Mn | 170.86 Mn | 13.18 Mn | 46.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 46.88 Mn |
| Dec 31, 2025 | 44.54 Mn |
| Sep 30, 2025 | 47.09 Mn |
| Jun 30, 2025 | 52.63 Mn |
| Mar 31, 2025 | 58.28 Mn |
| Dec 31, 2024 | 70.16 Mn |
| Sep 30, 2024 | 67.42 Mn |
| Jun 30, 2024 | 70.36 Mn |
| Mar 31, 2024 | 82.94 Mn |
| Dec 31, 2023 | 89.06 Mn |
| Sep 30, 2023 | 107.82 Mn |
| Jun 30, 2023 | 125.07 Mn |
| Mar 31, 2023 | 135.41 Mn |
| Dec 31, 2022 | 149.46 Mn |
| Sep 30, 2022 | 156.80 Mn |
| Jun 30, 2022 | 159.05 Mn |
| Mar 31, 2022 | 161.51 Mn |
| Dec 31, 2021 | 166.72 Mn |
| Sep 30, 2021 | 165.91 Mn |
| Jun 30, 2021 | 163.26 Mn |